Regulation of Coagulation Function in Patients with Cirrhosis Splenectomy by Thromboelastography

Hong JI,Jin-Long WANG,Yi-Ming LI,Hong-Wei LU,Le LU,Jia-Zhong WANG
DOI: https://doi.org/10.3969/j.issn.1003-4706.2014.12.033
2014-01-01
Abstract:Objective To investigate the coagulation function by thromboelastography and its clinical impact in patients with cirrhosis splenectomy.Methods 61 patients with cirrhosis splenectomy were treated with component transfusion under the guidance of TEG,and other 50 patients with cirrhosis splenectomy were treated with component transfusion under the guidance of conventional clotting tests. Liver function, the operative time,blood loss and hospitalization time was recorded and compared between the two groups.Results In TEG group,compared with the preoperative,the postoperative time of TEG R and K was shorter(P0.01), Plt,α angle,MA,G and CI was increased(P0.01).29 cases were treated with platelet(47.5%),17 cases were treated with cryoprecipitate(27.9%),6 cases were treated with platelet and cryoprecipitate(9.8%).There was no significant difference reported between preoperative and postoperative in PT and APTT(P 0.05).In control group,compared with the preoperative, the postoperative Plt and FIB was increased(P0.01).There was no significant difference between preoperative and postoperative in PT,PTA,INR and APTT(P0.05).23 cases were treated with platelet(46.0%), 6 cases were treated with cryoprecipitate(12.0%),6 cases were treated with platelet and cryoprecipitate(12.0%). Compared with the preoperative, postoperative liver function was improved in both groups(P0.05). Compared with the control group,AST was decreased,ALB was increased, and the operative time, blood loss and hospitalization time was decreased in TEG group(P 0.05). There was no significant difference between two group in preoperative(P 0.05). Conclusion TEG provides a better assessment of coagulation function than conventional clotting tests in patients with cirrhosis splenectomy. TEG in patients with cirrhosis have suggested that rebalanced hemostasis exists in some patients. TEG needs to be clinically validated in terms of more clinical trials to study and regulate coagulation function in patients with cirrhosis.
What problem does this paper attempt to address?